Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Immunovant (IMVT) Tax Rate (2018 - 2026)

Immunovant filings provide 8 years of Tax Rate readings, the most recent being 1.42% for Q4 2025.

  • Quarterly Tax Rate fell 129.0% to 1.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.79% through Dec 2025, down 65.0% year-over-year, with the annual reading at 0.22% for FY2025, 0.0% changed from the prior year.
  • Tax Rate hit 1.42% in Q4 2025 for Immunovant, down from 0.47% in the prior quarter.
  • Across five years, Tax Rate topped out at 1.64% in Q1 2023 and bottomed at 1.42% in Q4 2025.
  • Average Tax Rate over 5 years is 0.22%, with a median of 0.14% recorded in 2024.
  • The largest annual shift saw Tax Rate surged 161bps in 2023 before it tumbled -195bps in 2024.
  • Immunovant's Tax Rate stood at 0.08% in 2021, then tumbled by -850bps to 0.62% in 2022, then surged by 134bps to 0.21% in 2023, then plummeted by -165bps to 0.14% in 2024, then crashed by -939bps to 1.42% in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Tax Rate are 1.42% (Q4 2025), 0.47% (Q3 2025), and 0.76% (Q2 2025).